Risk models for recurrence and survival after kidney cancer: a systematic review

Author:

Usher‐Smith Juliet A.1ORCID,Li Lanxin2,Roberts Lydia2ORCID,Harrison Hannah1ORCID,Rossi Sabrina H.3ORCID,Sharp Stephen J.4,Coupland Carol5,Hippisley‐Cox Julia6,Griffin Simon J.1,Klatte Tobias7ORCID,Stewart Grant D.8ORCID

Affiliation:

1. Primary Care Unit Department of Public Health and Primary Care University of Cambridge CambridgeUK

2. School of Clinical Medicine University of Cambridge CambridgeUK

3. Department of Oncology Addenbrooke’s Hospital University of Cambridge CambridgeUK

4. MRC Epidemiology Unit University of Cambridge CambridgeUK

5. School of Medicine University of Nottingham NottinghamUK

6. Nuffield Department of Primary Care Health Sciences University of Oxford OxfordUK

7. Royal Bournemouth Hospital BournemouthUK

8. Department of Surgery Addenbrooke’s Hospital University of Cambridge Cambridge UK

Funder

Medical Research Council Canada

Cancer Research UK

National Institute for Health Research

Publisher

Wiley

Subject

Urology

Reference73 articles.

1. American Urological Association (AUA) guideline: follow‐up for clinically localized renal neoplasms;Donat SM;AUA Clin Guidel,2013

2. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up;Escudier B;Ann Oncol,2019

3. LjungbergB AlbigesL BedkeJet al.EAU guidelines on renal cell carcinoma[Internet] 2021. Available at:https://uroweb.org/guideline/renal‐cell‐carcinoma/. Accessed August 2021

4. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review;Sun M;Eur Urol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3